arrow
N

Nathalie Ganne-Carrié

Centre de Recherche des Cordeliers
H指数:60
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The APA Score Stratifies Prognosis in Patients with hepatocellular carcinoma Treated with Atezolizumab-Bevacizumab

APA评分可分层预测接受阿替利珠单抗-贝伐珠单抗治疗肝细胞癌患者的预后

2026-10-140
PRE
Second-Line Practices in the Era of Immunotherapy in HCC: The CHIEF Cohort

免疫治疗时代下肝癌的二线治疗实践:CHIEF队列

2026-06-120
OAAI
Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma

血清降钙素原: 诊断和监测纤维板层肝癌的新型肿瘤生物标志物

2026-02-060
PRE
COVID-19 and chronic liver disease: results from the 1219 patients French registry

COVID-19与慢性肝病:来自1219名患者法国登记研究的结果

2025-10-070
OA
Early Hemostatic Treatment Could Improve 30-Day Survival After Spontaneous Rupture of Hepatocellular Carcinoma

早期止血治疗可能改善肝癌自发性破裂后的30天生存率

2025-09-240
OAAI
Real-World Outcomes of Atezolizumab–Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort

阿特珠单抗–贝伐珠单抗在肝细胞癌中的真实世界结局:法国前瞻性CHIEF队列研究

2025-09-040
OAAI
The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment

早期MRI在评估不可逆电穿孔治疗肝细胞癌后局部肿瘤进展风险中的作用

2025-05-280
OA
Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma

经皮射频消融治疗肝细胞癌期间肿瘤和非肿瘤活检的应用价值

2025-04-220
OAAI
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis

非侵入性检测动态在指导肝硬化患者HCV治愈后HCC监测决策中的价值

2025-02-260
PRE
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
2024-11-010
OAAI
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
2024-08-012
OAAI
Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)
2024-07-051
OAAI